Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Repair of Superior Sinus Venosus Atrial Septal Defect Using a Modified Two-Patch Technique.

Elzein C, Abdulkarim M, Abbas U, Vricella L, Ilbawi M.

Ann Thorac Surg. 2019 Aug 28. pii: S0003-4975(19)31246-9. doi: 10.1016/j.athoracsur.2019.07.023. [Epub ahead of print]

PMID:
31472131
2.

Presentation to HIV care and antiretroviral therapy initiation and response in clinical practice from 2003 through 2013.

Pallotta AM, Pirzada SA, Shrestha RK, Yen-Lieberman B, Calabrese LH, Taege AJ, Butler RS, Abbas UL.

Int J STD AIDS. 2019 Aug;30(9):853-860. doi: 10.1177/0956462419841219. Epub 2019 Jul 7. No abstract available.

PMID:
31280687
3.

Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study.

Abbas UL, Glaubius RL, Ding Y, Hood G.

PLoS One. 2019 Jul 3;14(7):e0218649. doi: 10.1371/journal.pone.0218649. eCollection 2019.

4.

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.

Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL.

J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282.

5.

Anomalous Origin of Left Coronary Artery - an unusual case.

Abbas U, Cossor W.

Images Paediatr Cardiol. 2018 Apr-Jun;20(2):1-4.

6.

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.

Glaubius RL, Parikh UM, Hood G, Penrose KJ, Bendavid E, Mellors JW, Abbas UL.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw125. eCollection 2016 Sep.

7.

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.

Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL.

Clin Infect Dis. 2016 Aug 15;63(4):539-47. doi: 10.1093/cid/ciw321. Epub 2016 May 18.

8.

Giant coronary sinus aneurysm and multiple coronary artery aneurysms in a pediatric patient.

Abbas U, Brownlee J, Adebo D.

Images Paediatr Cardiol. 2015 Jan-Mar;17(1):1-3. No abstract available.

9.

Antiretroviral treatment, preexposure prophylaxis, and drug resistance in sub-Saharan Africa: a consensus among mathematical models.

Abbas UL, Glaubius R, Hood G, Mellors JW.

J Infect Dis. 2014 Jan 1;209(1):164-6. doi: 10.1093/infdis/jit545. Epub 2013 Oct 16. No abstract available.

PMID:
24133186
10.

Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.

van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB.

AIDS. 2013 Nov 28;27(18):2943-51. doi: 10.1097/01.aids.0000433237.63560.20.

PMID:
23939237
11.

Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW.

J Infect Dis. 2013 Jul 15;208(2):224-34. doi: 10.1093/infdis/jit150. Epub 2013 Apr 9.

12.

Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP).

Abbas UL, Hood G, Wetzel AW, Mellors JW.

PLoS One. 2011 Apr 15;6(4):e18165. doi: 10.1371/journal.pone.0018165.

13.

Uptake of biomedical interventions for prevention of sexually transmitted HIV.

Abbas UL.

Curr Opin HIV AIDS. 2011 Mar;6(2):114-8. doi: 10.1097/COH.0b013e328343ad7e. Review.

PMID:
21505385
14.
15.

Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.

Abbas UL, Anderson RM, Mellors JW.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):632-41. Erratum in: J Acquir Immune Defic Syndr. 2006 Jun;42(2):262.

PMID:
16652038
16.

Nerve conduction and sensorineural function in dental hygienists using high frequency ultrasound handpieces.

Cherniack M, Brammer AJ, Nilsson T, Lundstrom R, Meyer JD, Morse T, Neely G, Peterson D, Toppila E, Warren N, Atwood-Sanders M, Michalak-Turcotte C, Abbas U, Bruneau H, Croteau M, Fu RW.

Am J Ind Med. 2006 May;49(5):313-26.

PMID:
16570257
17.
18.

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Abbas UL, Mellors JW.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13377-8. Epub 2002 Oct 7. Review. No abstract available.

19.

Infectious diseases journals on the World Wide Web: attractions and limitations.

Abbas UL, Yu VL.

Clin Infect Dis. 2001 Sep 15;33(6):817-28. Epub 2001 Aug 6.

PMID:
11512087
20.

Late natural history of corneal topography after excimer laser photorefractive keratectomy.

Abbas UL, Hersh PS; Summit PRK Study Group.

Ophthalmology. 2001 May;108(5):953-9.

PMID:
11320027
21.

Early corneal topography patterns after excimer laser photorefractive keratectomy for myopia.

Abbas UL, Hersh PS.

J Refract Surg. 1999 Mar-Apr;15(2):124-31.

PMID:
10202706
22.

Natural history of corneal topography after excimer laser photorefractive keratectomy.

Abbas UL, Hersh PS.

Ophthalmology. 1998 Dec;105(12):2197-206.

PMID:
9855147

Supplemental Content

Support Center